| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 60.373 | 61.457 | 218.678 | 420.680 | 1.031.527 | 220.779 |
| Total Income - EUR | - | - | - | - | 60.373 | 61.457 | 218.733 | 426.772 | 1.037.081 | 270.321 |
| Total Expenses - EUR | - | - | - | - | 7.004 | 7.451 | 204.091 | 351.716 | 882.580 | 250.330 |
| Gross Profit/Loss - EUR | - | - | - | - | 53.369 | 54.007 | 14.642 | 75.056 | 154.500 | 19.991 |
| Net Profit/Loss - EUR | - | - | - | - | 52.807 | 53.559 | 12.924 | 71.711 | 143.841 | 16.626 |
| Employees | - | - | - | - | 1 | 1 | 1 | 1 | 1 | 3 |
Check the financial reports for the company - Apexor S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 955 | 937 | 1.942 | 4.482 | 8.867 | 35.781 |
| Current Assets | - | - | - | - | 53.264 | 53.554 | 87.148 | 269.004 | 345.263 | 226.133 |
| Inventories | - | - | - | - | 0 | 0 | 48.465 | 110.409 | 133.938 | 134.502 |
| Receivables | - | - | - | - | 49.244 | 41.941 | 23.892 | 130.867 | 117.571 | 18.647 |
| Cash | - | - | - | - | 4.020 | 11.613 | 14.791 | 27.728 | 93.754 | 72.984 |
| Shareholders Funds | - | - | - | - | 52.849 | 53.608 | 12.973 | 71.760 | 143.890 | 89.629 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 1.370 | 883 | 76.117 | 201.726 | 210.240 | 172.943 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7112 - 7112" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Apexor S.r.l.